Neuroimaging in Parkinson's disease.

Area of Science:

• Neuroimaging
• Neurology
• Radiology

Background:

• Parkinsonian disorders present limited findings in traditional structural imaging.
• Neurochemical changes, key to these disorders, are better visualized with functional imaging (PET, SPECT).
• Differentiating idiopathic Parkinson's from atypical parkinsonian disorders (MSA, PSP) remains a clinical challenge.

Purpose of the Study:

• To review recent advancements in both functional and structural neuroimaging for basal ganglia disorders.
• To highlight the potential of novel magnetic resonance imaging (MRI) techniques.
• To explore how imaging can elucidate disease pathogenesis and neurochemical alterations.

Main Methods:

• Review of recent literature on functional imaging (PET, SPECT) in Parkinsonian disorders.
• Analysis of emerging structural MRI techniques: spectroscopy, diffusion weighted imaging (DWI), diffusion tensor imaging (DTI), and magnetization transfer (MT).
• Comparison of imaging findings in idiopathic Parkinson's disease, multiple system atrophy (MSA), and progressive supranuclear palsy (PSP).

Main Results:

• Functional imaging (PET, SPECT) reveals profound neurochemical changes not evident in standard structural scans.
• Advanced MRI techniques (spectroscopy, DWI, DTI, MT) demonstrate potential in differentiating between idiopathic Parkinson's and atypical parkinsonian disorders.
• These advanced methods offer improved diagnostic capabilities for complex basal ganglia disorders.

Conclusions:

• Novel structural MRI techniques show significant promise for differential diagnosis in Parkinsonian syndromes.
• Functional imaging provides crucial insights into the underlying neurochemical mechanisms and pathogenesis.
• Integrated use of advanced functional and structural imaging is key to understanding and diagnosing basal ganglia disorders.